# 2026-12143: Company Seeks License to Import Government-Grade THC

2026-12143, Importer of Controlled Substances Application: AndersonBrecon, Inc. DBA PCI Pharma Services, is a Federal Register notice from Justice Department, Drug Enforcement Administration published 2026-06-17, effective Registered bulk manufacturers of the affected basic class(es), and applicants, therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before July 17, 2026. Such persons may also file a written request for a hearing on the application on or before July 17, 2026.; PRIA reads it as touching household money (as of 2026-06-24).

- Canonical: https://policyrisk.com/federal-register/2026-12143
- As of: 2026-06-24
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2026-12143
- Title: Importer of Controlled Substances Application: AndersonBrecon, Inc. DBA PCI Pharma Services
- Type: Notice
- Agencies: Justice Department; Drug Enforcement Administration
- Citation: 91 FR 36616
- Published: 2026-06-17
- Effective: Registered bulk manufacturers of the affected basic class(es), and applicants, therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before July 17, 2026. Such persons may also file a written request for a hearing on the application on or before July 17, 2026.
- Comments close: 2026-07-17
- Significant: no
- Touches household money: yes
- Regulation identifier numbers: none
- Last updated: 2026-06-24

## In one line

Company Seeks License to Import Government-Grade THC

## Summary

AndersonBrecon, Inc. DBA PCI Pharma Services wants to become an official importer of certain controlled substances, including some strong drugs like tetrahydrocannabinols. People and companies involved with these drugs can share their thoughts or ask for a hearing by July 17, 2026. This move could impact how these substances are brought into the U.S., but no costs or fees were mentioned yet.

## Abstract

AndersonBrecon, Inc. DBA PCI Pharma Services has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

## Effects PRIA read

- Application to Import Schedule I Drugs: benefit, low. On May 7, 2026, AndersonBrecon, Inc. DBA PCI Pharma Services applied to be registered to import three Schedule I controlled substances: tetrahydrocannabinols (drug code 7370), 3,4-methylenedioxymethamphetamine (drug code 7405), and dimethyltryptamine (drug code 7435). The company states it plans to…
- No Authorization for Commercial Finished Dosage Imports: cost, low. The notice explicitly states that any authorization will not extend to the import of Food and Drug Administration-approved or non-approved finished dosage forms for commercial sale. Approval of a registration will be limited to activities consistent with 21 U.S.C. 952(a)(2).

## Related documents

- [2026-11526](https://policyrisk.com/federal-register/2026-11526): Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 201…, 2026-06-09
- [2026-10128](https://policyrisk.com/federal-register/2026-10128): Revision of Applications for Manufacturing and Procurement Quotas, 2026-05-20
- [2025-05007](https://policyrisk.com/federal-register/2025-05007): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-03-24
- [2025-02793](https://policyrisk.com/federal-register/2025-02793): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-02-19
- [2026-20749](https://policyrisk.com/federal-register/2026-20749): Vladimir Romaniv, P.A.; Decision and Order, 2026-10-09
- [2026-20750](https://policyrisk.com/federal-register/2026-20750): L Krenk DBA Maui Clinic Pharmacy; Decision and Order, 2026-10-09

## Sources
- [2026-12143 on federalregister.gov](https://www.federalregister.gov/documents/2026/06/17/2026-12143/importer-of-controlled-substances-application-andersonbrecon-inc-dba-pci-pharma-services)
- [2026-12143 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2026-06-17/pdf/2026-12143.pdf)

## Related
- [Previous: 2026-12142, Importer of Controlled Substances Application: Aphena Pharma Solutions MD, LLC](https://policyrisk.com/federal-register/2026-12142)
- [Next: 2026-12144, Importer of Controlled Substances Application: Wedgewood Pharmacy LLC](https://policyrisk.com/federal-register/2026-12144)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2026-12143 (as of 2026-06-24).